tiprankstipranks
Blueprint Medicines (BPMC)
NASDAQ:BPMC
US Market

Blueprint Medicines (BPMC) Technical Analysis

Compare
563 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Blueprint Medicines’s (BPMC) Moving Averages Convergence Divergence (MACD) indicator is -2.63, suggesting Blueprint Medicines is a Buy.
Blueprint Medicines’s (BPMC) 20-Day exponential moving average is 100.74, while Blueprint Medicines’s (BPMC) share price is $92.25, making it a Sell.
Blueprint Medicines’s (BPMC) 50-Day exponential moving average is 100.23, while Blueprint Medicines’s (BPMC) share price is $92.25, making it a Sell.

Blueprint Medicines (BPMC) Pivot Points

Feb 22, 2025, 10:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
89.06
91.09
92.72
94.75
96.38
98.41
100.04
Fibonacci
91.09
92.49
93.35
94.75
96.15
97.01
98.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Blueprint Medicines (BPMC) Moving Averages

Feb 22, 2025, 10:04 AM
Period
Simple
Exponential
MA5
93.42Sell
94.36Sell
MA10
97.64Sell
97.53Sell
MA20
105.27Sell
100.74Sell
MA50
99.50Sell
100.23Sell
MA100
95.54Sell
98.10Sell
MA200
98.64Sell
98.06Sell
Blueprint Medicines’s (BPMC) 10-Day exponential moving average is 97.53, while Blueprint Medicines’s (BPMC) share price is $92.25, making it a Sell.
Blueprint Medicines’s (BPMC) 100-Day exponential moving average is 98.10, while Blueprint Medicines’s (BPMC) share price is $92.25, making it a Sell.
Blueprint Medicines’s (BPMC) stock price is $92.25 and Blueprint Medicines’s (BPMC) 50-day simple moving average is 99.50, creating a Sell signal.
Blueprint Medicines’s (BPMC) stock price is $92.25 and Blueprint Medicines’s (BPMC) 100-day simple moving average is 95.54, creating a Sell signal.
Blueprint Medicines’s (BPMC) stock price is $92.25 and Blueprint Medicines’s (BPMC) 200-day simple moving average is 98.64, creating a Sell signal.

Blueprint Medicines (BPMC) Technical Indicators

Feb 22, 2025, 10:04 AM
Name
Value
Implied Action
RSI (14)
34.05
Neutral
STOCH (9,6)
14.29
Buy
STOCHRSI (14)
10.72
Buy
MACD (12,26)
-2.63
Buy
ADX (14)
28.65
Neutral
Williams %R
-94.36
Buy
CCI (14)
-106.93
Buy
ATR (14)
4.33
-
Ultimate Oscillator
38.35
Neutral
ROC
-18.02
Sell
Blueprint Medicines’s (BPMC) Relative Strength Index (RSI) is 34.05, creating a Neutral signal.
Blueprint Medicines’s (BPMC) Trend Strength Indicator (ADX) is 28.65, creating a Neutral signal.
Blueprint Medicines’s (BPMC) Commodity Channel Index (CCI) is -106.93, creating a Buy signal.
Blueprint Medicines’s (BPMC) Price Rate of Change (ROC) is -18.02, creating a Sell signal.

FAQ

Is BPMC a Buy, Hold, or Sell?
Based on BPMC’s technical indicators, BPMC is a Sell.
    What is BPMC’s RSI (14)?
    BPMC’s RSI (14) is 34.05, which suggests BPMC is a Neutral.
      What is BPMC’s MACD?
      BPMC’s MACD is -2.63, which suggests BPMC is a Buy.
        What is BPMC’s 5-day moving average?
        BPMC’s 5-day moving average is 93.42, which suggests BPMC is a Sell.
          What is BPMC’s 20-day moving average?
          BPMC 20-day moving average is 105.27, which suggests BPMC is a Sell.
            What is BPMC’s 50-day moving average?
            BPMC’s 50-day moving average is 99.50, which suggests BPMC is a Sell.
              What is BPMC’s 200-day moving average?
              BPMC’s 200-day moving average is 98.64, which suggests BPMC is a Sell.
                What is BPMC’s Williams % R (14)?
                BPMC’s Williams % R (14) is -94.36, which suggests BPMC is a Buy.
                  What is BPMC’s CCI (14)?
                  BPMC’s CCI (14) is -106.93, which suggests BPMC is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis